Required (Core) Course
- PIBS 750: Biomedical Innovation II (Fall only)
Two Pre-Approved Electives
- ENTR 520.001: Technology-Inspired Business Models
- ENTR 560: Project Management & Consulting
- ENTR 599: Entrepreneurship in Pharmacy
- ENTR 510: Compensation, Fund. & Ownership
- ENTR 599: ELP Entrepreneurial Leadership
- ENTR 530: Innovation and IP Strategy
- ES 515: Introduction to Entrepreneurship
- ES 615: New Venture Creation
- ES 620: Healthcare Startups
- ES 623: Venture Capital Finance
- ES 629: Financing Research Commercialization
- ES 640: Building Healthy Business
- ES 701: Wolverine Venture Fund
- ES 702: Zell Lurie Commercialization Fund
- ES 720: Commercialization of Biomedicine
- Phrmacol 622: Translational Pharmacology
- Phrmacol 621: Drug Discovery
- Phrmacol 620: Business of Biology
- BIOMEDE 550: Ethics & Enterprise
- BIOMEDE 588: Global Quality Systems & Regulatory Innovation
- MKT 625: New Product & Innovation Management
- Petition Course* (reviewed by committee)
Students must earn a minimum grade of “B” (3.0 GPA) or higher in all required and elective courses in order to be counted toward the certificate program.
*Since the University of Michigan has an ever evolving list of course offerings related to innovation, entrepreneurship, and biomedical technologies that students may be interested in, we will allow students the option to petition for additional courses outside of this pre-approved course list to be considered for elective credit in the certificate program. For consideration, courses must be graduate level, relatable to certificate program, and enhance student experience or knowledge in biomedical commercialization. To have an additional course considered, please fill out our Intent to Apply Form and send Jon Servoss (servossj@umich.edu) the course syllabi.